Dr. Faria Farhat, MD

Dr. Farhat practices at Kaiser Permanente Gaithersburg Medical Center - Mammography in Gaithersburg, Maryland.

Dr. Farhat's NPI, 1790732139, was assigned on May 30, 2006. Dr. Farhat holds District of Columbia license MD034565.

Dr. Farhat's primary practice is Kaiser Permanente Gaithersburg Medical Center - Mammography, at 655 Watkins Mill Rd., Gaithersburg, MD 20879. The practice phone is (877) 390-0033.

Dr. Farhat's primary practice is Kaiser Permanente Gaithersburg Medical Center - Mammography in Gaithersburg, Maryland. Dr. Farhat is also affiliated with MedStar Washington Hospital Center. The medical group on file is Mid-Atlantic Permanente Medical Group. Dmand AI also links Dr. Farhat to 1 more hospital and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farhat practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Farhat's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dmand AI has Dr. Farhat's licenses on file in 3 states: District of Columbia, Maryland and Virginia.

CMS data shows 27 Medicare services from Dr. Farhat across 1 procedure code in 2019, for 13 Medicare patients. Medicare paid $1,685 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 13 Medicare patients who saw Dr. Farhat in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high blood pressure. Their average risk score is 2.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Farhat's median patient age at 49, with 57% women.

In 2024, Dr. Farhat wrote 470 Medicare Part D claims for 104 patients. 41% of them were for generic drugs. CMS names the drug for 329 of them, across 13 drugs with 11 or more claims each, at $2,163,100 in total drug cost. In 2023, CMS named 353 claims across 12 drugs.

Dr. Farhat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Farhat, published from 2012 to 2015. The most frequent topics are HIV Infections. Dr. Farhat has published most often in J Natl Med Assoc. Dr. Farhat's most frequent co-authors are Rabia Cherqaoui, MD, Yared Endailalu, MD and Sujay Madduri, MD.

CMS Open Payments shows 1 general payment to Dr. Farhat from 1 drug or device company in 2024. Food and beverage make up the largest share, 100% of the total. Revance Therapeutics, Inc. paid the most, $24.